We are live on ! Find out more
PIMJS

PKO Investment Management Joint-Stock Portfolio holdings

AUM $1.38B
1-Year Est. Return 59.54%
This Fund
S&P 500
This Quarter Est. Return
-19.17%
1 Year Est. Return
+59.54%
3 Year Est. Return
+124.73%
5 Year Est. Return
+130.21%
10 Year Est. Return
+742.49%
AUM
$695M
AUM Growth
-$133M
Cap. Flow
+$43.2M
Cap. Flow %
6.22%
Top 10 Hldgs %
48.93%
Holding
129
New
12
Increased
37
Reduced
40
Closed
3

Sector Composition

Rank Sector Weight
1 Materials 14.94%
2 Technology 14.58%
3 Energy 9.05%
4 Healthcare 8.52%
5 Consumer Discretionary 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
101
Becton Dickinson
BDX
$50B
$740K 0.11%
3,000
-75
-2% -$19K
REGN icon
102
Regeneron Pharmaceuticals
REGN
$82.2B
$709K 0.1%
1,200
CCL icon
103
Carnival Corporation Ltd
CCL
$37.9B
$692K 0.1%
80,000
EW icon
104
Edwards Lifesciences
EW
$53.6B
$685K 0.1%
7,200
-3,278
-31% -$339K
BSX icon
105
Boston Scientific
BSX
$74.5B
$634K 0.09%
+17,000
New +$692K
CALY
106
Callaway Golf Company
CALY
$2.95B
$612K 0.09%
30,000
DXCM icon
107
DexCom
DXCM
$34.3B
$596K 0.09%
8,000
+3,200
+67% +$292K
PVH icon
108
PVH
PVH
$3.76B
$569K 0.08%
+10,000
New +$691K
ILMN icon
109
Illumina
ILMN
$29.1B
$553K 0.08%
3,084
-288
-9% -$73.5K
IQV icon
110
IQVIA
IQV
$39.8B
$499K 0.07%
+2,300
New +$499K
A icon
111
Agilent Technologies
A
$41.9B
$499K 0.07%
+4,200
New +$516K
MRNA icon
112
Moderna
MRNA
$25.4B
$453K 0.07%
3,171
BAX icon
113
Baxter International
BAX
$13.9B
$450K 0.06%
+7,000
New +$508K
BVN icon
114
Compañía de Minas Buenaventura
BVN
$8.79B
$389K 0.06%
58,942
+36,942
+168% +$319K
IDXX icon
115
Idexx Laboratories
IDXX
$45B
$386K 0.06%
+1,100
New +$449K
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$133B
$338K 0.05%
1,200
-1,300
-52% -$348K
ARVN icon
117
Arvinas
ARVN
$580M
$337K 0.05%
8,000
+3,500
+78% +$176K
BG icon
118
Bunge Global
BG
$21.5B
$307K 0.04%
3,390
BIIB icon
119
Biogen
BIIB
$30.9B
$286K 0.04%
+1,400
New +$286K
CCCC icon
120
C4 Therapeutics
CCCC
$480M
$264K 0.04%
+35,000
New +$308K
FTCH
121
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$215K 0.03%
30,000
SA
122
Seabridge Gold
SA
$3.5B
$210K 0.03%
17,000
INCY icon
123
Incyte
INCY
$24.5B
$190K 0.03%
2,500
-3,500
-58% -$266K
OGN icon
124
Organon & Co
OGN
$3.59B
$33.3K ﹤0.01%
986
KGC icon
125
Kinross Gold
KGC
$32.6B
$17.8K ﹤0.01%
5,006

Similar funds

PKO Investment Management Joint-Stock's Q2 2022 Portfolio in Review

As of Q2 2022, PKO Investment Management Joint-Stock held 129 positions worth $695M, down 16% from $828M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

PKO Investment Management Joint-Stock deployed $43.2M of net new capital in Q2 2022, opening 12 new positions and adding to 37 existing holdings. Its largest new stake was EOG Resources: 34,000 shares worth $3.75M.

By sector, the portfolio is most concentrated in Materials at 15% of assets, down from 20% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Apple, an estimated $3.79M trimmed.

  • PKO Investment Management Joint-Stock's largest Q2 2022 buy was EOG Resources: 34,000 shares worth $3.75M.
  • PKO Investment Management Joint-Stock added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $20.7M increase.
  • PKO Investment Management Joint-Stock's biggest Q2 2022 reduction was Apple, cutting an estimated $3.79M.
  • PKO Investment Management Joint-Stock fully exited Vale in Q2 2022, selling an estimated $1.1M.
  • PKO Investment Management Joint-Stock's ten largest holdings make up 49% of its $695M portfolio in Q2 2022.
  • PKO Investment Management Joint-Stock opened 12 new positions and closed 3 in Q2 2022.
  • PKO Investment Management Joint-Stock's portfolio value fell 16% quarter-over-quarter to $695M.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2022, filed 13 Mar 2025.